• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

SLS Venture

edit

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus.

The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. € 270 M (USD 325 M) under management.

Recent Milestones

edit

• 
  SLS Venture invested in Action Pharma. (7/16/10)
  Posted 7/16/10 at 5:59pm via onbiovc.com
• 
  SLS Venture invested in AdvanDx. (10/12/09)
  Posted 10/12/09 at 6:05pm via onbiovc.com
• 
  SLS Venture invested in OxThera. (6/29/07)
  Posted 3/12/10 at 5:25am via oxthera.com
• 
  SLS Venture invested in OxThera. (7/11/05)
  Posted 7/2/10 at 4:06am via oxthera.com

Investments

Videos

Sources

1. Action Pharma, A/S: Series C $6.3M (onbiovc.com) [edit]
2. AdvanDx, Inc.: Series C $8M (onbiovc.com) [edit]
3. OxThera Raises SEK 150 Million in New Round of Financing (oxthera.com) [edit]
4. External financing of SEK 165 million secured for Q-Med's oxalate project (oxthera.com) [edit]